Wrexham Maelor Hospital
Wrexham, United Kingdom
Hospital in Wrexham, Wales
Croesnewydd Rd, Wrexham LL13 7TD
800 Beds
About Wrexham Maelor Hospital
The Wrexham Maelor Hospital is a district general hospital for the north east region of Wales. It is managed by Betsi Cadwaladr University Health Board.
There are 800 beds in Wrexham Maelor Hospital.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Lisette Nixon
4
University of Edinburgh
3
University College, London
2
Wales Cancer Trials Unit
2
Allena Pharmaceuticals
1
Boston Scientific Corporation
1
Dr. Negrin University Hospital
1
ETOP IBCSG Partners Foundation
1
Institute of Cancer Research, United Kingdom
1
Integra LifeSciences Services
1
Intercytex
1
Clinical Trials at Wrexham Maelor Hospital
During the past decade, Wrexham Maelor Hospital conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 3 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Timing of Surgery and Chemotherapy in Treating Patients With Newly Diagnosed Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
2003-09-01
Completed
150
Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
2005-03-01
Unknown status
2,421
Safety and Efficacy Study of ICXP007 With Compression Bandaging for the Treatment of Non-Infected Venous Leg Ulcers
2005-07-01
Unknown status
396
Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery
2005-12-16
2024-09-01
Active, not recruiting
4,400
CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen
2004-03-01
Unknown status
200
Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer
2006-01-01
2015-10-01
Unknown status
1,404
Dexamethasone and Chemotherapy With or Without Plasma Exchange in Patients With Newly Diagnosed Multiple Myeloma and Acute Kidney Failure
2003-03-01
2008-12-01
Completed
280
Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
2006-09-01
2013-03-01
Completed
1,110
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Wrexham Maelor Hospital" #1 sponsor was "Lisette Nixon" with 4 trials, followed by "University of Edinburgh" with 3 trials
sponsored, "University College, London" with 2 trials sponsored, "Wales Cancer Trials Unit" with 2 trials sponsored and "Allena Pharmaceuticals"
with 2 trials sponsored. Other sponsors include 14 different institutions and
companies that sponsored additional 24 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Wrexham Maelor Hospital"
#1 collaborator was "Cancer Research UK" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "NHS Lothian" with 2 trials as a collaborator, "Asociación Científica Pulmón y Ventilación Mecánica" with 1 trials as a collaborator and "Australian and New Zealand Intensive Care Research Centre" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were
collaborators in the rest 26 trials.
Clinical Trials Conditions at Wrexham Maelor Hospital
According to Clinical.Site data, the most researched conditions in "Wrexham Maelor Hospital" are
"Breast Cancer" (3 trials), "Fallopian Tube Cancer" (3 trials), "Ovarian Cancer" (3 trials), "Colorectal Cancer" (2 trials) and "Oesophageal Cancer" (2 trials). Many other conditions were trialed in "Wrexham Maelor Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Wrexham Maelor Hospital
Most popular intervention types in "Wrexham Maelor Hospital" are "Drug" (21 trials), "Biological" (5 trials), "Procedure" (5 trials), "Radiation" (5 trials) and "Other" (4 trials). Other intervention types were less common.
The name of intervention was led by "capecitabine" (5 trials), "Placebo" (3 trials), "Radiotherapy" (2 trials), "adjuvant therapy" (2 trials) and "cetuximab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Wrexham Maelor Hospital
The vast majority of trials in "Wrexham Maelor Hospital" are
27 trials for "All" genders and 4 trials for "Female" genders.
Clinical Trials Status at Wrexham Maelor Hospital
Currently, there are NaN active trials in "Wrexham Maelor Hospital".
undefined are not yet recruiting,
6 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 13 completed trials in Wrexham Maelor Hospital,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Wrexham Maelor Hospital, 0 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 15 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 6 trials that are defined as “Not Applicable".